share_log

4: Statement of changes in beneficial ownership of securities-Director Farley Chele Chiavacci

4: Statement of changes in beneficial ownership of securities-Director Farley Chele Chiavacci

4:持股變動聲明-董事 Farley Chele Chiavacci
美股SEC公告 ·  12/21 06:10

Moomoo AI 已提取核心訊息

Farley Chele Chiavacci, associated with Conduit Pharmaceuticals, has reported a transaction scheduled for 12/18/2024. The reporting person's address is listed as 4851 Tamiami Trail North, Suite 200, Naples, FL, 34103.While the announcement provides the date of the earliest transaction, it does not disclose the nature, volume, or value of the securities involved. The relationship between the reporting person and the issuer is not specified in the provided information.It's important to note that this report is for a future transaction, as the date provided (12/18/2024) has not yet occurred. Investors should be aware that the lack of detailed transaction information limits the ability to assess the potential impact on the company's stock.
Farley Chele Chiavacci, associated with Conduit Pharmaceuticals, has reported a transaction scheduled for 12/18/2024. The reporting person's address is listed as 4851 Tamiami Trail North, Suite 200, Naples, FL, 34103.While the announcement provides the date of the earliest transaction, it does not disclose the nature, volume, or value of the securities involved. The relationship between the reporting person and the issuer is not specified in the provided information.It's important to note that this report is for a future transaction, as the date provided (12/18/2024) has not yet occurred. Investors should be aware that the lack of detailed transaction information limits the ability to assess the potential impact on the company's stock.
Farley Chele Chiavacci與Conduit Pharmaceuticals有關,報告了一筆計劃於2024年12月18日進行的交易。報告人的地址爲4851 Tamiami Trail North, Suite 200, Naples, FL, 34103。雖然公告提供了最早交易的日期,但未披露涉及證券的性質、成交量或價值。報告人與發行人之間的關係在提供的信息中未明確說明。需要注意的是,此報告是針對未來的交易,因爲提供的日期(2024年12月18日)尚未發生。投資者應注意,缺乏詳細的交易信息限制了評估對公司股票潛在影響的能力。
Farley Chele Chiavacci與Conduit Pharmaceuticals有關,報告了一筆計劃於2024年12月18日進行的交易。報告人的地址爲4851 Tamiami Trail North, Suite 200, Naples, FL, 34103。雖然公告提供了最早交易的日期,但未披露涉及證券的性質、成交量或價值。報告人與發行人之間的關係在提供的信息中未明確說明。需要注意的是,此報告是針對未來的交易,因爲提供的日期(2024年12月18日)尚未發生。投資者應注意,缺乏詳細的交易信息限制了評估對公司股票潛在影響的能力。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息